Gilead's Kite exits China cell therapy joint venture with Fosun Pharma

cafead

Administrator
Staff member
  • cafead   Sep 19, 2024 at 09:32: PM
via Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the 50-50 cell-therapy-focused joint venture with Fosun Pharma.

article source